Halbert Hargrove Global Advisors, LLC Astrazeneca PLC Transaction History
Halbert Hargrove Global Advisors, LLC
- $1.76 Billion
- Q1 2025
A detailed history of Halbert Hargrove Global Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Halbert Hargrove Global Advisors, LLC holds 21 shares of AZN stock, worth $1,460. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21Holding current value
$1,460% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,381Shares Held
475MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.2 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$2.85 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.61 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.67 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.36 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $216B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...